Search Results - Marlies Stützle‐Schnetz

First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers by Antje Blank, Nicolas Hohmann, Marlen Dettmer, Anette Manka‐Stuhlik, Gerd Mikus, Felicitas Stoll, Marlies Stützle‐Schnetz, Daniel Thomas, Evelyn Exner, Beate Schmitt‐Bormann, Torsten Schaller, Rico Laage, Oliver Schönborn‐Kellenberger, Michaela Arndt, Walter E. Haefeli, Jürgen Krauss

Connect to this object online.